Enfusion (ENFN) News Today $10.63 +0.16 (+1.53%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Analysts Set Enfusion, Inc. (NYSE:ENFN) PT at $9.40December 21 at 1:09 AM | americanbankingnews.comEnfusion price target raised to $13 from $11 at StifelDecember 20 at 6:17 AM | markets.businessinsider.comEnfusion, Inc. (NYSE:ENFN) Receives Consensus Rating of "Reduce" from BrokeragesShares of Enfusion, Inc. (NYSE:ENFN - Get Free Report) have earned an average recommendation of "Reduce" from the five brokerages that are currently covering the stock, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a sell recommendation, one has given a holDecember 18 at 2:11 PM | marketbeat.comStifel Nicolaus Forecasts Strong Price Appreciation for Enfusion (NYSE:ENFN) StockStifel Nicolaus upped their target price on Enfusion from $11.00 to $13.00 and gave the company a "buy" rating in a research report on Wednesday.December 18 at 12:27 PM | marketbeat.comEnfusion (NYSE:ENFN) Hits New 52-Week High - Time to Buy?Enfusion (NYSE:ENFN) Sets New 12-Month High - Still a Buy?December 17, 2024 | marketbeat.comEnfusion, Inc. (NYSE:ENFN) Shares Purchased by Wellington Management Group LLPWellington Management Group LLP raised its position in Enfusion, Inc. (NYSE:ENFN - Free Report) by 6.7% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 976,296 shares of the company's stock after purchasiDecember 16, 2024 | marketbeat.com414,982 Shares in Enfusion, Inc. (NYSE:ENFN) Purchased by TenCore Partners LPTenCore Partners LP purchased a new position in Enfusion, Inc. (NYSE:ENFN - Free Report) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 414,982 shares of the company's stock, valued at approximately $3,938December 6, 2024 | marketbeat.comEnfusion, Inc. (NYSE:ENFN) COO Neal Pawar Sells 21,801 SharesDecember 5, 2024 | insidertrades.comReadystate Asset Management LP Has $1.04 Million Stake in Enfusion, Inc. (NYSE:ENFN)Readystate Asset Management LP grew its stake in Enfusion, Inc. (NYSE:ENFN - Free Report) by 173.7% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 109,243 shares of the company's stock after purchasing an additionalDecember 5, 2024 | marketbeat.com91,315 Shares in Enfusion, Inc. (NYSE:ENFN) Purchased by PDT Partners LLCPDT Partners LLC acquired a new stake in Enfusion, Inc. (NYSE:ENFN - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 91,315 shares of the company's stock, valued at approximately $867,000. PDT Partners LLCDecember 3, 2024 | marketbeat.comEnfusion, Inc. (NYSE:ENFN) Shares Could Be 35% Below Their Intrinsic Value EstimateDecember 2, 2024 | finance.yahoo.com272 Capital LP Trims Holdings in Enfusion, Inc. (NYSE:ENFN)272 Capital LP lowered its stake in shares of Enfusion, Inc. (NYSE:ENFN - Free Report) by 47.3% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 73,325 shares of the company's stock after selling 65,855 shares during the period. 272 Capital LP owned approxiDecember 1, 2024 | marketbeat.comBrown Capital Management LLC Sells 1,365,923 Shares of Enfusion, Inc. (NYSE:ENFN)Brown Capital Management LLC lessened its holdings in Enfusion, Inc. (NYSE:ENFN - Free Report) by 15.9% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 7,208,596 shares of the company's stock after selling 1,365,923 shares duriNovember 21, 2024 | marketbeat.comEnfusion To Present at Upcoming Investor EventsNovember 21, 2024 | gurufocus.comEnfusion To Present at Upcoming Investor EventsNovember 20, 2024 | businesswire.comImpax Asset Management Group plc Increases Stake in Enfusion, Inc. (NYSE:ENFN)Impax Asset Management Group plc boosted its stake in Enfusion, Inc. (NYSE:ENFN - Free Report) by 25.4% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 676,948 shares of the company's stock after purchasing an additionaNovember 16, 2024 | marketbeat.com52,800 Shares in Enfusion, Inc. (NYSE:ENFN) Bought by Versor Investments LPVersor Investments LP purchased a new stake in shares of Enfusion, Inc. (NYSE:ENFN - Free Report) during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund purchased 52,800 shares of the company's stock, valued at approximately $501,000. Other hedge funds havNovember 15, 2024 | marketbeat.comEnfusion, Inc. (NYSE:ENFN) Short Interest Down 22.4% in OctoberEnfusion, Inc. (NYSE:ENFN - Get Free Report) was the target of a large decrease in short interest in the month of October. As of October 31st, there was short interest totalling 1,180,000 shares, a decrease of 22.4% from the October 15th total of 1,520,000 shares. Approximately 2.4% of the shares of the stock are short sold. Based on an average trading volume of 381,300 shares, the short-interest ratio is presently 3.1 days.November 15, 2024 | marketbeat.comThere May Be Some Bright Spots In Enfusion's (NYSE:ENFN) EarningsNovember 13, 2024 | finance.yahoo.comEnfusion (NYSE:ENFN) Sees Large Volume Increase - Here's WhyEnfusion (NYSE:ENFN) Sees Unusually-High Trading Volume - Here's What HappenedNovember 8, 2024 | marketbeat.comQ3 2024 Enfusion Inc Earnings CallNovember 6, 2024 | sg.finance.yahoo.comEnfusion Third Quarter 2024 Earnings: Misses ExpectationsNovember 6, 2024 | finance.yahoo.comEnfusion, Inc. (NYSE:ENFN) Q3 2024 Earnings Call TranscriptNovember 6, 2024 | msn.comEnfusion: A Strategic Opportunity with High Growth Potential and Attractive ValuationNovember 6, 2024 | markets.businessinsider.comImpax Asset Management Group plc Increases Holdings in Enfusion, Inc. (NYSE:ENFN)Impax Asset Management Group plc raised its stake in Enfusion, Inc. (NYSE:ENFN - Free Report) by 25.4% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 676,948 shares of the company's stock after acquirNovember 6, 2024 | marketbeat.comNew York State Common Retirement Fund Has $14.77 Million Stock Position in Enfusion, Inc. (NYSE:ENFN)New York State Common Retirement Fund reduced its holdings in shares of Enfusion, Inc. (NYSE:ENFN - Free Report) by 6.4% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,556,470 shares of the company's stock after selling 107,008November 6, 2024 | marketbeat.comEnfusion Announces Third Quarter 2024 ResultsNovember 5, 2024 | uk.finance.yahoo.comEnfusion: Strong Client Acquisitions and Strategic Positioning Drive Buy RatingNovember 5, 2024 | markets.businessinsider.comEnfusion Inc (ENFN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...November 5, 2024 | finance.yahoo.comWilliam Blair Remains a Buy on Enfusion (ENFN)November 5, 2024 | markets.businessinsider.comEnfusion Q3 Revenue Rises; Revises OutlookNovember 4, 2024 | markets.businessinsider.comEnfusion, Inc. (ENFN) Q3 2024 Earnings Call TranscriptNovember 4, 2024 | seekingalpha.comEnfusion, Inc. 2024 Q3 - Results - Earnings Call PresentationNovember 4, 2024 | seekingalpha.comEnfusion Inc (ENFN) Q3 2024: Everything You Need to Know Ahead of EarningsNovember 2, 2024 | finance.yahoo.comEnfusion: 3 Strength, 3 Caveats, 3 Ways For Extra Income And Margin Of SafetyOctober 30, 2024 | seekingalpha.comWhy Private Equity Will Buyout EnfusionOctober 30, 2024 | seekingalpha.comShort Interest in Enfusion, Inc. (NYSE:ENFN) Decreases By 14.1%Enfusion, Inc. (NYSE:ENFN - Get Free Report) saw a large decrease in short interest during the month of October. As of October 15th, there was short interest totalling 1,520,000 shares, a decrease of 14.1% from the September 30th total of 1,770,000 shares. Based on an average trading volume of 376,900 shares, the short-interest ratio is presently 4.0 days. Currently, 3.1% of the shares of the stock are short sold.October 29, 2024 | marketbeat.comEnfusion (ENFN) Scheduled to Post Earnings on MondayEnfusion (NYSE:ENFN) will be releasing earnings before the market opens on Monday, November 4, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=632965)October 28, 2024 | marketbeat.comEnfusion, Inc.'s (NYSE:ENFN) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?October 21, 2024 | finance.yahoo.comEnfusion, Inc. (ENFN): This Fintech Stock Is Riding the AI Wave HigherOctober 18, 2024 | msn.comSG Americas Securities LLC Makes New Investment in Enfusion, Inc. (NYSE:ENFN)SG Americas Securities LLC purchased a new position in Enfusion, Inc. (NYSE:ENFN - Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 94,032 shares of the company's stock,October 12, 2024 | marketbeat.comEnfusion Announces Key Leadership Team Additions to Drive Client Success and Fuel InnovationOctober 10, 2024 | tmcnet.comEnfusion, Inc. (NYSE:ENFN) Shares Bought by Dimensional Fund Advisors LPDimensional Fund Advisors LP lifted its holdings in shares of Enfusion, Inc. (NYSE:ENFN - Free Report) by 57.5% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 524,142 shares of the company's stock afterOctober 10, 2024 | marketbeat.comSquarepoint Ops LLC Purchases Shares of 80,126 Enfusion, Inc. (NYSE:ENFN)Squarepoint Ops LLC purchased a new position in Enfusion, Inc. (NYSE:ENFN - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 80,126 shares of the company's stock, valued at approximateOctober 9, 2024 | marketbeat.comEnfusion, Inc. (NYSE:ENFN) Shares Purchased by Renaissance Technologies LLCRenaissance Technologies LLC increased its stake in shares of Enfusion, Inc. (NYSE:ENFN - Free Report) by 167.6% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 97,100 shares of the company's stock afteOctober 8, 2024 | marketbeat.comEnfusion (NYSE:ENFN) Stock Quotes, Forecast and News SummaryOctober 5, 2024 | benzinga.comEnfusion Announces Date of Third Quarter 2024 ResultsOctober 4, 2024 | tmcnet.comClearline Capital LP Sells 70,738 Shares of Enfusion, Inc. (NYSE:ENFN)Clearline Capital LP cut its stake in Enfusion, Inc. (NYSE:ENFN - Free Report) by 27.9% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 183,174 shares of the company's stock after selling 70,738 shares durinSeptember 29, 2024 | marketbeat.com3 Stocks That Might Be Undervalued In September 2024September 26, 2024 | finance.yahoo.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Enfusion, Inc. - ENFNSeptember 25, 2024 | prnewswire.com Get Enfusion News Delivered to You Automatically Sign up to receive the latest news and ratings for ENFN and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight. >> Register for the Workshop Now ENFN Media Mentions By Week ENFN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ENFN News Sentiment▼0.920.65▲Average Computer and Technology News Sentiment ENFN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ENFN Articles This Week▼72▲ENFN Articles Average Week Get Enfusion News Delivered to You Automatically Sign up to receive the latest news and ratings for ENFN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AI News QLYS News VRNS News INTA News FRSH News ZETA News TENB News BOX News BRZE News CLBT News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:ENFN) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enfusion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enfusion With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ENFN Stock Alerts